START & Sarah Cannon Partner to Advance Therapies for Patients with Cancer
South Texas Research Accelerated Therapeutics (START) and Sarah Cannon Research Institute announced a new collaboration to complement and enhance their globally recognized phase I...
BioProtect begins study of ProSpace biodegradable spacer to protect rectum, lower GI tract during radiation therapy
BioProtect, the technology leader in biodegradable balloon spacers protecting normal tissue during radiation therapy, announced the launch of its clinical trial following Investigational Device...
Innovative Humanized Research Strategies for Immuno-Oncology Drug Development Crown Bioscience Hosts a Live Webinar
Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology,...
Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology
Thermo Fisher Scientific and Illumina, Inc. announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who...
Medivir completes pre-clinical safety studies with MIV-818 to treat hepatocellular carcinoma
Medivir AB, a research-based pharmaceutical company, announced the successful completion of the pre-clinical safety studies for MIV-818 to enable the start of phase I...
Akcea begins phase 2b study of AKCEA-APOCIII-LRx in patients with hypertriglyceridemia & established CVD
Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by...
Avelas completes patient enrollment in phase 2 study of AVB-620 in women with primary, nonrecurrent breast cancer undergoing surgery
Avelas Biosciences, a clinical stage oncology-focused company that is developing products to advance a new standard-of-care for cancer surgery and therapeutic intervention, announced the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...